Table 9. Grading system for local adverse events in sublingual immunotherapy (SLIT) according to the World Allergy Organisation (279).
Symptom/sign |
Pruritus/swelling of mouth, tongue, or lip; throat irritation*, nausea, abdominal pain, vomiting, diarrhea, heartburn, or uvular edema |
Grade 1: mild |
Not troublesome and no symptomatic treatment required and no discontinuation of SLIT because of local side effects |
Grade 2: moderate |
Troublesome or requires symptomatic treatment and no discontinuation of SLIT because of local side effects |
Grade 3: severe |
Grade 2 and SLIT discontinued because of local side effects |
Unknown severity |
Treatment is discontinued, but there is no subjective, objective, or both description of severity from the patient/physician |
Each local adverse event can be early (<30 min) or delayed. *, for example, itchy palate, burning or swelling of the throat.